Lipopolysaccharides from Distinct Pathogens Induce Different Classes of Immune Responses In Vivo

Bali Pulendran, Padmasini Kumar, Christopher W. Cutler, +3

The Journal of Immunology

Phase II Study of Belagenpumatucel-L, a Transforming Growth Factor Beta-2 Antisense Gene-Modified Allogeneic Tumor Cell Vaccine in Non–Small-Cell Lung Cancer

John Nemunaitis, Robert O. Dillman, Paul Schwarzenberger, +13

Journal of Clinical Oncology

Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer

Neil Senzer, Minal Barve, Joseph A. Kuhn, +23

Molecular Therapy

Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients

John Nemunaitis, Michael Nemunaitis, Neil Senzer, +7

Cancer Gene Therapy

Allogeneic Tumor VaccineTgf-β2 Antisense GeneTumor ImmunologyPhase Ii TrialMedicine +7

Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer

Jonathan Oh, Minal Barve, Carolyn M. Matthews, +19

Gynecologic Oncology

Vigil® DnaMedicineImmunologyPhase Ii StudyImmune Checkpoint Inhibitor +7

CAP37, a Novel Inflammatory Mediator

Taunia D. Lee, Melva L. Gonzalez, Padmasini Kumar, +3

American Journal Of Pathology

InflammationAnti-inflammatoryAutoimmune DiseaseImmunologyNovel Inflammatory Mediator +4

CAP37, a neutrophil-derived inflammatory mediator, augments leukocyte adhesion to endothelial monolayers

Taunia D. Lee, Melva L. Gonzalez, Padmasini Kumar, +2

Microvascular Research

InflammationCytokineNeutrophil-derived Inflammatory MediatorGranulocyteCell Adhesion +7

Expression of CAP37, a novel inflammatory mediator, in Alzheimer's disease

H. Anne Pereira, Padmasini Kumar, Paula Grammas

Neurobiology of Aging

InflammationAlzheimer's DiseaseCell SignalingMedicineImmunology +10

Phase I Trial of TGF-β2 Antisense GM-CSF Gene-Modified Autologous Tumor Cell (TAG) Vaccine

Jairo Olivares, Padmasini Kumar, Yang Yu, +10

Clinical Cancer Research

Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma

Maurizio Ghisoli, Minal Barve, Reva Schneider, +13

Molecular Therapy